The first two authors contributed equally to the work Adult skeletal muscle regeneration involves serial steps among which inflammation in the wounded area is critical for the healing process. However, accelerated tissue regeneration and the inhibition of excessive inflammation are always the targets of tissue engineering, because excessive inflammation in the early stage can impede the regeneration in the following step. In this study, a feasible ibuprofenloaded poly (L-Iactide) (PLLA) fibrous scaffold was designed to evaluate the ability of preventing excessive inflammatory response and promoting regeneration using 35 Sprague-Dawley (SO) rats. The cytotoxicity assay of PLLA and ibuprofen-loaded PLLA fibrous scaffolds (IBU/PLLA) showed that there were no significant cell cytotoxicity on L6 cells. The histological results showed that the IBUlPLLA group had slighter inflammation than PLLA and control groups during the whole process. In the later stage, the regeneration process of the IBU/PLLA group took place on the 7th day, which was almost more than one week earlier than the PLLA and control groups. qRT-PCR analysis further displayed that the IBUlPLLA group had a lower level of inflammatory factors and higher expression of repair factors than the PLLA and control groups, especially from the 7th day, and lasted until the 21st day. Furthermore, there were no statistical differences between the PLLA group and the control group from histological results and qRT-PCR analysis. Taken together, through the muscle wound healing process, the results demonstrated that the ibuprofen-loaded PLLA fibrous scaffolds had better control of excessive inflammation and faster process of healing than non-ibuprofen-Ioaded groups.
regeneration and fibrosis formation in severe injuries (I). When the cascade ofinflammatory events become disrupted, the excessive inflammation can lead to delayed healing of acute wounds or development of chronic non-healing wounds/ulcers (2) . Thus, in the repair of acute wounded skeletal muscle, inhibition of excessive inflammation and promotion of tissue regeneration are both equally important.
The intrinsic muscle repair system has a robust capacity to repair muscle damage, while severe traumatic injuries resulting in significant muscle tissue loss and gaps in muscle tissue are another matter (3) . When this happens, the tissue engineering, which was invented to help the body to complete the regeneration process is required (4) . Scaffolds are three-dimensional (3D) constructs engineered to support tissue formation. They are usually designed like extracellular matrix (ECM) to support cell attachment, proliferation and accelerate functionality formation of tissues or organs. An electrospinning technique is the only method capable of producing continuous polymeric nanofibers that can manipulate and control surface area, fiber diameter, the porosity of the nanofibrous layer and the base weight (5) .
Early attempts at skeletal muscle tissue engineering focused on improving vascularization by using a multi-culture system (6) , while some muscle tissue engineering work continues to explore the use of synthetic materials, for example, Thorrez et al. (7) used gas-foamed poly-lactide-co-glycolide (PLGA) scaffolds to support human myogenic cells on muscle repair. Fernandes et al. (8) studied the ability of matrixes to encourage myoblast differentiation and maturation using different maltodextrin-based matrix. However, they all focused on the regeneration of healing process and neglected the importance of anti-inflammation.
Inflammation in acutely damaged muscle is characterized by a rapid and sequential invasion of leukocytes that persists during muscle repair, regeneration, and growth (9) . Ibuprofen (lEU) is one kind of non-steroidal anti-inflammatory drug (NSAID) and is more suitable for long-term use (10) . Poly (L-Iactide) (PLLA) is a widely used biomedical polymer owing to its biodegradability and stability. The degradation products of PLLA are carbon dioxide (C0 2 ) and water, which is harmless for the body. Here, we fabricated ibuprofen-loaded electrospun fibers using the electrospinning technology. Through in vivo analysis of histological staining and mRNA expression of many cytokines, this ibuprofen-loaded electrospun fibrous scaffold was applied, not only as a medicine carrier material for inhibiting early excessive inflammation but as a scaffold for tissue engineering to accelerate the regeneration of wounded muscle in our rat models.
MATERIALS AND METHODS

Materials
Poly (L-lactide) (PLLA, Mw=lOOkDa, Mw/Mn=1.6) was purchased from Sigma. Dichloromethane (DCM), N, N-dimethylformamide (DMF) were reagent grades purchased from Sinopharm Chemical Reagent Co., Ltd. All other chemicals and solvents were of reagent grade or better and were purchased from GuoYao Regents Company (Shanghai, China), unless otherwise indicated.
Preparation ofelectrospun fibrous scaffold
Electrospinning was carried out according to our previous report (11). 1 g PLLA was completely dissolved in 4 g DCM and 2 g DMF for electrospun PLLA fibers. To prepare ibuprofen-loaded PLLA electrospun fibrous membranes (IBU/PLLA), 1 g PLLA and 40 mg IBU were completely dissolved in a mix-solvent containing 4 g DCM and 2 g DMF for electrospinning. The blended solvent was then put in a syringe pump that was attached to the high voltage device. A negative electrode blanketed with aluminum foil was used as the collector plate.
In vitro drug release
The electrospun fibrous scaffolds (weight, 100 mg) were simultaneously immersed in centrifuge tubes containing 25 mL phosphate buffered solution (PBS, pH=7.4). The samples were incubated at 37°C for 48 h with mild shaking (100 rpm). At predetermined time intervals, 1 mL buffer solution was collected and replaced with 1 mL fresh buffer solution. The amount of released drug in the collected medium was determined by UVvis spectroscopy at 224 nm. A standard calibration plot of IBU in the concentration range of 0-0.05 mg/mL was used to determine the concentration of the drug released. The percentage of the released drug was then calculated based on the initial weight of drug incorporated in the electrospun scaffolds.
eel/lines
The mouse myoblast L6 cell line was purchased from the Cellular Biology Institute of the Chinese Academy of Sciences (Shanghai, China). Cells were cultured in Dulbecco's modified Eagle culture medium (DMEM, Gibco) supplemented with penicillin-streptomycin (100 U/mL -0.1 mg/mL) (Gibco), and 10% fetal calf serum (FCS, Gibco), and kept at 37°C in an atmosphere of 5% CO 2 and humidified air. Media were changed every 3 days.
MTTassay
Cells were seeded in a 96-well tissue culture plate (Costar) at a concentration of 2x 10 4 cells/well in a medium volume of 100 ul., After overnight cell culture, the original cell culture medium was discarded and the extraction fluids were added. Briefly, the PLLA and IBU/ PLLA fibers were sectioned in the same size and precisely weighed using microbalance (SE MES, German Sartorius Instrument), sterilized by 75% ethyl alcohol and ultraviolet irradiation, then immersed in the same volume ofcomplete culture medium (2 mL) for 72 h, at 37°C. The quality of pure IBU was decided according to the IBU/PLLA fiber releasing equivalent amount of IBU during 72 h (from in vitro release data) and then dissolved in 2 mL of the complete culture medium for 72 h, at 37°C. The complete culture medium without materials was represented as control. The final 100 ul, pure solution of the extracts of PLLA, IBUIPLLA and IBU were added to cells. After 24, 48 and 72 h of incubation, the cell viability and apoptosis were evaluated by MTT. For the direct contact method, cells were seeded in a 24-well plate at a concentration of I x 10 5 cells/well. The samples of PLLA and IBU/PLLA cover approximately one-fifth of the cell layer surface in the center of each well. After 24, 48 and 72 h of incubation at 37°C, cell viability was determined using MTT assay. Briefly, following exposure to the specimen, 20 ul, MTT solution (2 mg/ml in PBS) was added to each well, and the plates were incubated for 4 h at 37°C. Then 200 ul, of Dimethylsulfoxide (DMSO) was added for solubilization and the optical density (OD) was read at 540 nm on a microplate reader (Titertek Multiskan, Brad, Austria). All assays were performed in triplicate. The OD of medium without cells was subtracted as background. The results were presented as reduction of metabolic activity in percentage when compared to control cells cultured in medium only (100%).
TUNEL staining
To confirm the presence of cell apoptosis following exposure to the specimen we performed in situ labeling of TUNEL (Terminal deoxynucleotide transferase dUTP nick end labeling)-positive nuclei using the In Situ Cell Death Detection Kit, POD (Roche, USA) according to the manufacturer's protocol. In brief, culture media in the wells was removed after treatments, and the cells were rinsed three times with PBS. Then the freshly prepared 4% paraformaldehyde in PBS added and incubated for 30 min at room temperature, after which 50 ul. of TUNEL reaction mixture was added to the wells and incubated for 60 min in a humidified chamber for at 37°C and rinsed three times with PBS. TUNEL staining was observed by inverted fluorescence microscopy (Olympus, Tokyo, Japan) and photographed using Image-Pro Plus 6.0 imaging system.
Animal and experimental design
All the procedures followed the policies of Shanghai Jiao Tong University School of Medicine and the National Institutes of Health. Male 8-week-old Sprague-Dawley rats (n=35) weighing 200-250g were obtained from the Animal Breeding Center, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China. The rats had free access to commercial chow and tap water and were subjected to a 12-hour light/dark cycle in individual boxes maintained at a constant temperature (22±2°C) and humidity (55%). All surgical procedures were performed under sterilised conditions and the rats were allowed to acclimatize for one week before the beginning of the experiment.
The animals were divided into two groups, control group (n=10) and experimental group (n=25). The rats were anesthetized using ketamine (1 ml/kg body weight) and the backs of the animals were shaved and sterilized with 75% EtOH. Each group received two incisions in the right and left antimere of the musculus sacrospinalis, separated by a distance of 2 cm. In the control group, the right and left lesions were sewn up without any scaffolds; in the experimental group, the left lesion was implanted with electrospun fibrous scaffolds (PLLA group) and the right lesion was implanted with ibuprofen-loaded electrospun fibrous scaffolds (IBUIPLLA group). The fiber scaffold implanted in every rat was sectioned as 0.5x 1.0 em', weighing 0.5 mg, and the content of IBU administered to each rat was approximately 25 ug. The animals in both groups were evaluated daily and were euthanized on days 1, 3, 7, 14 and 21 post-wounding (control group n=2; experimental group n=5). The muscle tissue samples from the wound site were excised in full depth and bisected from all of the rats for morphologic observation and gene expression level test.
Histological analysis
The specimens were then fixed in 10% formalin, processed, and embedded in paraffin. The proximal and distal side of the surgical incision were identified, and the specimens were cut at 3 mm intervals perpendicular to the long axis of the surgical incision using an Olympus microtome (Olympus, Tokyo, Japan). Hematoxylin and eosin staining was used to visualize the gross microscopic cellular architecture. A blinded pathologist examined the slides for assessment of healing and cellular infiltration.
RNA preparation and reverse transcription
Total RNA was extracted from frozen tissues with Trizol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions and quantified at a wavelength of 260 nm by NanoDrop spectrophotometry (Eppendorf, Hamburg, Germany). The integrity of RNA was verified by optical density absorption ratio OD260nmlOD280nm between 1.8 and 2.0. To obtain the cDNA, 2 ug of total RNA was reverse transcribed using M-MLV reverse transcriptase (Promega, Madison, USA) followed by amplification on Applied Biosystems ViiA™ 7 (Applied Biosystems Inc., Foster City, CA, USA).
Quantitative real-time peR
Aquantitative real-time PCR using Applied Biosystems ViiATM 7 (Applied Biosystems Inc., Foster City, CA, USA) was applied for detecting the relative IL-6, TNF-a, TGF-p, VEGF and bFGF mRNA levels in rat muscles. Relative expression levels of those gene transcripts were normalized to RNA loading for each sample using b-actin mRNA. Specific primers for all genes were designed by bioTNT (Shanghai, China) and manufactured by Invitrogen (Carlsbad, CA, USA). Sequences of sense and antisense primers for target genes and reference gene (b-actin) are shown in Table I . PCR reactions were performed in a final volume of 20 ul. volumes containing I ul, cDNA. The reactions were performed with the following settings: 5 min of pre-incubation at 95°C Table I . Different gene specific primers.
Sense followed by 40 cycles for 5 s at 95°C and 30 s at 60°C. All RT-PCR reactions were performed in triplicate. A reaction without cDNA was performed in parallel as negative control. Relative quantification was performed according to the comparative 2-<' >1' .0 method as described previously (12) . The result for the gene expression was given by a unitless value using the formula 2-<' >1' .0.
Statistical analysis
All data were recorded as mean ± standard deviations (SO). After testing the data for nonnal distribution and equal variance, differences between experiment groups and control group were analyzed by the unpaired t-test (SAS 9. I for Windows). The differences among experimental groups and control group were analyzed by ANOVA. P value < 0.05 was statistically considered to be significant. All experiments were performed at least three times.
RESULTS
The properties ofelectrospunfibres
The actual loading content ofIBU was determined to be close to the theoretic values for IBU-Ioaded electrospun fibers and the drug loading content was 3.91±O.22% of IBU/PLLA fibers with the initial addition of4% (IBU/PLLA, w/w). It can be seen that there are no beads in the fibrous structure and the fibers are uniform in size, randomly interconnected antisense IL-6 
a) Cytotoxicity of extracts of different materials tested on L6 cell line. b)The indirect test fo r viability evaluation ofL6 cells in the presence ofPLLA and IBU/PLLA materials. The results are presented as reduction of metabolic activity in percentage when compared with the negative control (cells without extracts ofmaterials, J00%).
as shown in Fig. 1 . The diameters of fibers were 1.29±0.35 and 1.35±0.28 J.1m for PLLA and IBUI PLLA e1ectrospun fibrous scaffolds, respectively. In vitro IBU release profiles of electrospun IBUI PLLA fibrous membranes are shown in Fig. lc , electro spun IBUIPLLA fibrous membrane released about 81.2% of loaded IBU within approximately 34 days with initial burst release of about 24.2% in the first 3 days . During the electrosp inning process, IBU would disperse throughout the fiber because IBU was completely dissolved into the electrospinning solution. Furthermore, a large amount drug would distribute on or close to the fiber surface because of the solvent evaporation (11). Therefore, the release profiles of drug-loaded fibers showed a typical biphasic pattern of a pronounced burst release in the initial phase and a gradual release followed during the rest of the time.
Cell viability assay
The fiber scaffold tested in every well weighed 0.5 mg, so the content ofIBU loaded on the fiber was about 25 J.1g. For the indirect method, the absorbance values obtained from different material extracts were comparable to the negative control (medium without material extracts ) as shown in Fig. 2a . The cell viability between the extract s and negative control showed no significant difference . In the direct contact
Fig. 3. Identification ofapoptotic cells using TUNEL staining. Untreated cells compared with cells treated with PLLA and IBu/PLLA . (x200)
method as shown in Fig. 2b , the absorbance values showed no reduction in cell metabolic activity in PLLA and IBUIPLLA groups , which indicated that in this test there were no significant cell cytotoxicity of PLLA and IBU/PLLA.
Apoptosis detection using TUNEL staining
In TUNEL staining, viable cells with intact nuclei resisted the dye, while the stained apoptotic cells in were demonstrated by the appearance of cell shrinkage with condensation and breaking up of the nuclei. This procedure was used to quantify the number of apoptotic cells after treatment with materials . Staining with TUNEL of the cells treated with PLLA and IBUIPLLA at different times (Fig.  3) showed there were no significant differences compared to the negative control.
Histological staining
As shown in Fig. 4 , in the control group, the inflammatory cell infiltration was most significant on the 3rd day. At this stage we noticed a mass of inflammatory cells dispersively infiltrated in the intermuscular septum, which widened the intermuscular septum. This phenomenon lasted until the 7th day, and on the 14th day there was still a small quantity of inflammatory cells infiltrated into the intermuscular septum of the control group and the tissue structure became clear and normal on the 21st day post-operation. In the PLLA group, the tendencies of inflammatory cell infiltration were similar to the control group , namely the inflammatory response erupted on day 3 and continued to day 7 and resulted in the disorder of tissue structure. This condition improved on the 14th day and the muscle fibers had normal morphology and regular arrangement on day 21. In the IBU/PLLA group, similarly the greatest inflammatory cell infiltration presented on the 3rd day, but they were of a lighter degree than the control group and PLLA group. On day 7 the infiltration became slight and the structure of the intermuscular septum began to clear. On the 14th day, the muscle fibers had normal arrangement and the intermuscular septum had a regular structure. The muscle tissues became completely normal on day 21.
qPT-PCR analysis ofIL-6
The relative expression ofIL-6 of the lBU/PLLA group was significantly different from other two groups (P < 0.05) as shown in Fig. 5 . Especially, on the 7th day, at the peak of all groups, the expression of IL-6 of lBU/PLLA group was almost four times lower than the control group and three times lower than the PLLA group, while there was no significant difference between PLLA group and control group on the relative expression of IL-6.
qPT-PCR analysis ofTNF-a As shown in Fig. 6 , the whole variation tendency ofTNF-a was similar in all groups, but the expression of TNF-a of the IBU/PLLA group maintained the lowest level throughout compared to the other groups (P < 0.05). Though during the first seven days the expression of TNF-a of the PLLA group was somewhat higher than control group, there was no significant difference between the PLLA group and the control group on the relative expression of TNF-a.
qPT-PCR analysis of VEGF
The relative expression of VEGF in IBU/PLLA group became higher than others from the 3rd day and kept this superiority till the 21st day and the significant rise appeared on the 7th day ( Fig. 7) . As can be seen, the relative expression of VEGF had significant difference between the IBU/PLLA group and the other two groups (P < 0.05), while there was no significant difference between the PLLA group and the control group during the whole process.
qPT-PCR analysis ofTGF-fJ
As shown in Fig. 8 , the expression of TGF-ĩ ncreased in sequence from the control group, PLLA group to IBU/PLLA group, starting from the 1st day after operation till the 21st day. On the 7th day, the expression of TGF-~increased dramatically in the IBU/PLLA group. The key point was that the expression of TGF-~in the IBU/PLLA group was constantly higher than the others during the whole observation (P < 0.05); even on the 21st day the relative expression ofTGF-~ofthe IBU/PLLAgroup stayed at twice as much as that of the control group.
qPT-PCR analysis ofbFGF
The relative expression of bFGF in the IBUI PLLA group became markedly higher than others from the 7th day, and till the 21st day the higher level ofbFGF in the IBU/PLLA group remained in spite of this superiority not being distinct ( Fig. 9 ). Therefore, there was significant difference between the IBUI PLLA group and the other two groups (P< 0.05), while there was no significant difference between the PLLA group and the control group during the whole process.
DISCUSSION
Acute injuries to muscles are very common in daily life and incomplete healing is responsible for individual morbidity. Despite many improvements in the currently available therapies involving autografts or allografts (13) , significant limitations remain in the management of these conditions. Biological grafts have drawbacks such as donor scarcity, donor-site morbidity, tissue rejection and disease transmission (14) . These shortcomings have led to alloplastic materials being a valuable alternative source in reconstructive procedures (15) . An ideal material for wound healing would have the following properties: (I) to be of cytocompatible natural or artificial materials; (2) with minimal inflammatory possibility, disease transmission and host immune response; and (3) of optimal micro-architecture to promote efficient cell infiltration and attachment (16) .
Skeletal muscle regeneration is an adaptive response to injury or disease (9) and during this process inflammation is initiated first (1). Neutrophils contribute to the early muscle membrane lysis following injury through a superoxide-dependent mechanism and the release of myeloperoxidase (9) . Ibuprofen has specific activity against neutrophils, including inhibition of neutrophil migration, which has been demonstrated in previous studies (17) , therefore, we loaded ibuprofen in PLLA fibers hoping to effectively control the inflammation at an early stage. To demonstrate the morphological changes, we applied histological staining and the results showed that the difference in healing condition between the ibuprofen-loaded group and the other groups (control and PLLA groups) were significant in morphology. In the control group and the PLLA group, the inflammatory cell infiltration lasted until the 14th day and the tissue structure regained normal till the 21st day post-operation. In the IBU/PLLA group, the greatest inflammatory cell infiltration had a lighter degree than the control group and the PLLA group, and on day 7 the infiltration became slight and the structure of intermuscular septum began to clear; this is because of ibuprofen, which can control the excessive inflammation in the first few days and the lighter exudation of leukocyte can speed the healing process.
In order to confirm the results and quantify the relative expression of cytokines, the qRT-PCR of genes mRNA expression was carried out. In inflammatoryresponse, interleukin (IL )-6 is important in chemotaxis and activation of inflammatory cells (18) and tumor necrosis factor (TNF)-a is a potent pro-inflammatory cytokine that influences various cell types and the chronic inflammatory process by recruiting polymorphonuclear cells and other immune cells, thereby contributing to the amplification and progression of the inflammatory process (19) . In our results, the relative expression ofIL-6 and TNF-a of the IBU/PLLA group kept the lowest level compared to the control group and the PLLA group during the whole observation. These results indicated that the animals treated with Ibuprofen-loaded electrospun fibrous scaffolds showed significantly lower levels of IL-6 and TNF-a compared with the control and PLLA groups in wound healing, which means the inflammatory response in the IBU/PLLA group was slighter than in the other groups.
Among the growth factors involved in the process of wound healing, vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-~) and basic fibroblast growth factor (bFGF) have been shown to play key roles. VEGF is an angiogenic peptide produced by endothelial cells, macrophages and many other cells (20) , which plays an important role in the stimulation of angiogenesis in wounds (21) .
TGF-~is known to be the most potent growth factor involved in wound healing throughout the body. TGF-b is released by degranulated platelets at the site of injury and influences the inflammatory response, angiogenesis, reepithelialization, extracellular matrix deposition and remodeling (22) . In skeletal muscle, members of the TGF-~superfamily have been shown to have potent effects on both muscle development and postnatal skeletal muscle mass by modulating myoblast activity and inhibiting both proliferation and differentiation (23) . bFGF is a potent mitogen for fibroblasts and keratinocytes, involved in the proliferative phase of wound repair (24) . In our results, these cytokines increased from the 1st day to the 14th day, afterwards which the expression level decreased until the 21st day. These results suggest that the animals treated with ibuprofen-loaded electrospun fibrous scaffolds showed significantly higher levels ofVEGF, TGF-~and bFGF compared with other groups of wound healing, which means the tissues repair process in the IBU/PLLA group was earlier and faster than the other groups.
In general, the ibuprofen-loaded electrospun fibrous scaffolds can improve the wound healing in muscle wounds of rat models. It has the abilities not only to release drugs as a drug carrier for controlling the excessive inflammation in the early stage of the wounded area, but also accelerates regeneration as scaffolds in the later stage. That means they had a synergistic effect of anti-inflammation and regeneration i one treatment of wounded tissue.
